Pentixather
Pentixather is a radiolabeled peptide that targets CXCR4. By disrupting the interaction between leukemia cells and the bone marrow microenvironment through targeting the CXCR4/CXCL12 signaling axis, Pentixather reduces the retention of leukemia cells in protective bone marrow niches, thereby increasing their sensitivity to treatment. It is applicable in studies related to acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) .
Product Specifications
Molecular Weight
701.83
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP39646_T100-HRP 100 µL
ZSCAN16 Antibody - N-terminal region : HRP (ARP39646_T100-HRP)
Sign In for Pricing
View Details